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Staphylococcus aureus encodes many proteins that act as virulence factors, leading to a variety of diseases,
including mastitis in cows. Among these virulence factors, SpA, ClfA, ClfB, FnbA, and FnbB are important for
the ability of S. aureus to adhere to and invade host cells as well as to evade host immune responses. The
interaction between these S. aureus surface proteins and human immunoglobulin G and fibrinogen that are
coupled to latex particles is utilized to induce latex agglutination reactions, which are used widely in diagnostic
kits for confirmation of presumptive S. aureus isolates. In this study, the Staphaurex latex agglutination test
was performed on a collection of confirmed bovine mastitis S. aureus isolates. Notably, 54% (43/79 isolates) of
these isolates exhibited latex agglutination-negative phenotypes (Staphaurex-negative result). To gain insights
into the reasons for the high frequency of Staphaurex-negative bovine mastitis S. aureus isolates, the spa, clfA,
clfB, fnbA, and fnbB genes were examined. Specific genetic changes in spa, clfA, and fnbA, as well as a loss of
fnbB, which may impair SpA, ClfA, FnbA, and FnbB functions in latex agglutination reactions, were detected
in Staphaurex-negative S. aureus isolates. The genetic changes included a premature stop codon in the spa gene,
leading to a truncated SpA protein that is unable to participate in S. aureus cell-mediated agglutination of latex
particles. In addition, clfA and fnbA genetic polymorphisms were detected that were linked to ClfA and FnbA
amino acid changes that may significantly reduce fibrinogen-binding activity. The genetic variations in these
S. aureus isolates might also have implications for their bovine mastitis virulence capacity.
Although Staphylococcus aureus strains are natural inhabit-
ants of bovine skin and mucous epithelia, these bacteria can
also infect bovine mammary glands, leading to mastitis. This
process involves numerous cell surface virulence factors that
promote cellular attachment and invasion as well as evasion of
host immune responses and induction of toxic tissue reactions
(24). The initial attachment of S. aureus to epithelial cells of
the teat canal depends on the interaction of bacterial surface
proteins, such as clumping factors A and B (ClfA and ClfB)
and fibronectin-binding proteins A and B (FnbA and FnbB),
with host fibrinogen and fibronectin proteins located in the
basement membrane, around myoepithelial cells and fibro-
blasts (2, 21, 29, 37, 41). ClfB, apart from the iron-regulated
surface determinant IsdA and the serine-aspartic acid repeat
proteins SdrC and SdrD, was also shown to be important for
the adhesion of S. aureus to squamous cells (9). Moreover, S.
aureus is able to invade epithelial and endothelial cells as well
as fibroblasts via binding of FnpA and -B to fibronectin, which
provides a bridge to the 51 integrin of host cells (34). The
role of the fibronectin-binding proteins in adhesion and inva-
sion of cells has also been shown for bovine mammary gland
cells (25), but strain-associated differences were observed (7,
18).
Additionally, the S. aureus ClfA and -B and FnbA and -B
proteins are involved in the evasion of host immune responses
that may be directed against these pathogens. Based on their
ability to bind fibrinogen on the S. aureus cell wall, they inhibit
deposition of or access to opsonins to the pathogen (20). ClfA
has been shown to impede macrophage phagocytosis (31) and
to bind and activate the complement regulator factor I, thereby
inactivating C3b, the central complement component (15).
Other S. aureus surface proteins involved in host immune eva-
sion are protein A (SpA) and IsdH (40). The immunoglobulin
G (IgG)-binding SpA protein, in addition to B-cell superanti-
genic properties, has the capacity to coat the S. aureus cell
surface with incorrectly oriented IgG molecules, thereby pre-
venting phagocytosis as well as classical pathway complement
fixation (3). Moreover, the ability of S. aureus to survive inside
polymorphonuclear neutrophils contributes to immune eva-
sion (13).
Adhesion and invasion levels, as well as the ability of intra-
cellular S. aureus to induce apoptosis, depend on the bacterial
growth phase and are subjected to regulation via the accessory
gene regulator (agr) locus and the staphylococcal accessory
regulator A (SarA) protein family (8, 25, 42). SarA upregulates
the expression of clfB and fnbA and -B during the exponential
growth phase, whereas agr downregulates spa and fnbA and -B
expression in the postexponential growth phase (8). Although
clfA is transcribed throughout the growth cycle, this gene is
highly expressed in the postexponential growth phase (44).
Additionally, agr- and sarA-dependent functions upregulate
the expression of the four S. aureus hemolysins (alpha to
delta) (8).
The Staphaurex test kit is a latex agglutination-based diag-
nostic tool that is used widely for the confirmation of putative
S. aureus isolates. The function of this kit depends on the
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interaction of S. aureus surface-anchored proteins SpA, ClfA,
ClfB, FnbA, and FnbB with human IgG and fibrinogen pro-
tein, which are bound on the surfaces of latex particles. These
protein-protein interactions therefore mediate latex particle
agglutination, which leads to visible clots in the case of a
Staphaurex test positive (Staphaurex-positive) result, thereby
confirming presumptive S. aureus organisms. As such, the spec-
ificity and sensitivity of this diagnostic test depend on the
presence and proper function of the above-mentioned proteins
on the surface of S. aureus. Some studies have reported low
sensitivities and specificities for bovine S. aureus detection with
latex agglutination-based tests, but the possible reasons for
such observations have not yet been examined (35, 45).
The objectives of the present study were to characterize
Staphaurex-negative and -positive bovine S. aureus isolates
through evaluation of the genes corresponding to the Staphau-
rex test proteins, i.e., SpA, ClfA, ClfB, FnbA, and FnbB, as
well as their expression. We could thereby assign potential
reasons for the Staphaurex-negative results among our collec-
tion of bovine mastitis S. aureus isolates.
MATERIALS AND METHODS
Bacterial isolates and growth conditions. A total of 79 presumptive S. aureus
isolates were recovered from 78 cows coming from 61 herds in Switzerland.
Bovine milk sample collection and isolation and identification of presumptive S.
aureus organisms were done in accordance with International Dairy Federation
(IDF) recommendations (20a). Subsequently, a previously described S. aureus
species-specific 23S rRNA gene PCR analysis (36) was used to confirm the
nature of the isolates. The isolates were stored at 70°C until used, at which time
respective samples were streaked out onto sheep blood agar and incubated for 18
to 24 h at 37°C. Single S. aureus colonies were used for the analysis. Individual
S. aureus colonies were inoculated into 10-ml cultures of brain heart infusion
broth (BHI broth; Oxoid AG, Pratteln, Switzerland). The cultures were grown at
37°C in a shaking incubator set at 150 rpm until the stationary growth phase (18
to 24 h).
Phenotypic methods. A latex agglutination test was performed on S. aureus
colonies following the instructions outlined in the Staphaurex test kit protocol
(Remel, Oxoid AG, Pratteln, Switzerland). The production of hemolysins was
determined on sheep blood agar, based on their interference with beta-hemoly-
sin produced by the ATCC 25923 strain, in accordance with previously described
classification criteria (26, 39). Based on these criteria, alpha () hemolysis is
denoted as total hemolysis that is acuminated in the area of beta () hemolysis,
which is partial hemolysis. Gamma () hemolysis refers to hemolysis which is
observed only on human or rabbit blood agar, while delta () hemolysis denotes
a CAMP-like total hemolysis in the area of beta hemolysis. The bovine S. aureus
isolates were also tested for their egg yolk reaction on Baird-Parker agar (Oxoid
AG, Pratteln, Switzerland) (4).
DNA purification. The S. aureus genomic DNA templates were extracted using
a DNeasy blood and tissue kit (Qiagen AG, Hombrechtikon, Switzerland).
Amplification of genes. Regions of the spa, clfA, clfB, fnbA, and fnbB genes
defined by the primers listed in Table 1 were amplified by conventional PCR. For
each PCR, 10 ng of S. aureus genomic DNA template, a 500 nM concentration
of each primer, and 25 l of 2 GoTaq mixture (Promega AG, Du¨bendorf,
Switzerland) were used in a 50-l reaction mix. Amplification was carried out in
a Biometra thermocycler (T3000), and the following parameters were applied:
denaturation for 3 min at 95°C; 40 cycles of 15 s at 95°C, 30 s at 56°C, and 30 s
(spa, clfA, and clfB), 60 s (fnbB), or 80 s (fnbA) at 72°C; and 5 min of extension
at 72°C.
spa and agr typing. The proline-rich repeat region of the spa gene was ampli-
fied from all S. aureus isolates (1), and the resulting amplicon sequences were
analyzed on the SpaServer website (http://www.spaserver.ridom.de/) to assign a
spa type to each isolate examined (16). The clonal complexes of the spa types
were determined with Ridom StaphType software (version 1.0; Ridom GmbH,
Wu¨rzburg, Germany). The agr groups (alleles) were determined by multiplex
PCR as described by Gilot et al. (12).
MLST. Multilocus sequence typing (MLST) was performed for a selected
number of isolates as described by Enright et al. (11). MLST results were
analyzed with eBurst software (version 3.0 [http://www.mlst.net]) and were as-
signed to clonal complexes.
Total RNA extraction. Stationary-phase S. aureus cultures were prepared by
growing single colonies in 10 ml BHI broth for 18 h at 37°C in a shaking
incubator (150 rpm). Respective stationary-phase cultures (1.5 ml) were mixed
with 3 ml of RNAprotect bacterial reagent (Qiagen AG, Hombrechtikon, Swit-
zerland) and incubated for 5 min at room temperature to stabilize the RNA
expression profiles before total RNA was extracted. Samples were centrifuged
(10 min at 5,000  g), and the bacterial cells were resuspended in 500 l of
lysis buffer provided in a Qiagen RNeasy Mini kit (Qiagen AG, Hombrech-
tikon, Switzerland). The samples were mechanically disrupted and total RNA
isolated from the lysates based on the RNeasy Plus Mini kit protocol. Total
RNA was eluted from the column into 50 l of RNase-free water, and the
RNA yield was determined using a NanoDrop ND-1000 instrument (Nano-
drop Instruments, DE).
cDNA synthesis. A total of 300 ng of total RNA from respective samples was
converted into cDNA in 20-l reaction mixtures, using a QuantiTect reverse
transcription kit (Qiagen AG, Hombrechtikon, Switzerland). Potential residual
DNA contamination in each total RNA sample was assessed by including a
control reaction without the reverse transcriptase enzyme (no-RT control) dur-
ing cDNA synthesis. A calibrator RNA sample derived from a Staphaurex-
positive S. aureus strain (isolate 1908) was included in each experimental run.
The cDNA synthesis mixtures were incubated for 30 min at 42°C and 3 min at
90°C and then cooled to 4°C.
Relative gene expression quantification. Quantification of spa, clfA, clfB, and
fnbA gene expression was performed using a LightCycler 480 real-time PCR
instrument (Roche Diagnostics [Schweiz] AG, Rotkreuz, Switzerland). The
quantitative RT-PCR (qRT-PCR) primers listed in Table 1 were used in 10-l
PCR mixtures which included LightCycler 480 SYBR green I master mix and
3.75 ng of diluted (1:10) cDNA template. The target gene transcripts were
quantified using LightCycler 480 Advanced relative quantification software. The
S. aureus DNA gyrB gene (43) and the 16S rRNA gene (10) were used as
reference genes following confirmation of their stable expression between the
different S. aureus isolates examined (32). Genomic DNA-based standard curves
were used to define target and reference gene PCR amplification efficiencies for
the different S. aureus isolates. These PCR efficiency values were applied in the
subsequent calculation of relative gene expression levels for each isolate. All S.
aureus isolates were assayed as duplicates in each experimental run, and in each
case, two independent biological assays were performed.
Analysis of genetic variations. The complete spa, clfA, and fnbA genes in
selected Staphaurex-negative and -positive S. aureus isolates were amplified
using the PCR primers listed in Table 1, and the sequences of the resulting
amplification products were determined. Based on spa, clfA, and fnbA gene
sequence differences detected in Staphaurex-negative S. aureus isolates, real-
time PCR primers (Table 1) were designed to specifically detect these sequence
polymorphisms. Such primers were subsequently applied in real-time PCR assays
to examine the frequencies of these detected genetic changes within the rest of
the bovine mastitis-derived S. aureus isolates. The sequenced Staphaurex-nega-
tive and -positive isolates were used as controls, and a no-template reaction mix
was used as a negative control.
PCR and gel purification. The PCR products were purified directly from
amplification reaction mixtures or after agarose gel separation and band excision,
using a MinElute PCR purification or MinElute gel extraction kit (Qiagen AG,
Hombrechtikon, Switzerland), respectively.
Protein extraction and SpA immunoblotting. S. aureus protein fractions were
extracted from selected isolates and immunoblotted as described by C. Quiblier
et al. (submitted for publication). In brief, cell fractions and supernatant were
sampled from a stationary-phase BHI culture. Cell wall fractions from each
isolate were obtained after digesting the cells with SMM buffer (0.5 M sucrose,
0.02 M maleate [pH 6.5], 0.02 M MgCl2) containing lysostaphin, lysozyme,
DNase, and phenylmethylsulfonyl fluoride (PMSF). After resuspending the pro-
toplasts in membrane buffer and lysing them by alternating freezing in liquid
nitrogen and thawing at 37°C, the cytoplasmic fractions were collected. The
membrane pellets were solubilized overnight at 4°C in solubilization buffer.
Twenty micrograms of protein from each isolate was separated in SDS-7.5%
polyacrylamide gels and blotted onto a polyvinylidene difluoride (PVDF) mem-
brane (Immobilon-P; Millipore AG, Zug, Switzerland). After blocking of the
membrane, it was incubated with goat anti-human IgA conjugated with horse-
radish peroxidase (HRP), diluted 1:2,000 in milk powder–phosphate-buffered
saline (PBS) and Tween 20 (AppliChem GmbH, Darmstadt, Germany). HRP
was detected with SuperSignal West Pico chemiluminescent substrate (Thermo-
FisherScientific, Lausanne, Switzerland).
VOL. 49, 2011 ALTERED VIRULENCE GENES IN Staphaurex-NEGATIVE S. AUREUS 639
Statistical analysis. Box plots were drawn using the PASW Statistics 18.0 pro-
gram (SPSS Schweiz AG, Zurich, Switzerland) to compare the gene expression
ratios of the Staphaurex-negative and -positive S. aureus groups. The statistical
significance of spa, clfA, and clfB gene expression differences between Staphaurex-
negative and -positive S. aureus groups was determined based on repeated analysis
of variance (ANOVA) measurements using the statistical program NCSS (NCSS,
East Kaysville, UT). P values of 0.05 were regarded as significant.
RESULTS
Phenotypic characterization. Phenotypic characterization
results for the 79 PCR-confirmed bovine mastitis-derived S.
aureus isolates examined in this study are summarized in
Table 2. Fifty-four percent (43/79 isolates) of the S. aureus
isolates were Staphaurex negative. Since the expression lev-
els of spa, clfB, fnbA, and fnbB are downregulated during the
stationary phase, which corresponds to the growth state in
colonies when the Staphaurex test is performed, we selected
three Staphaurex-negative isolates and examined them at all
growth stages. These isolates remained negative at all
growth stages, indicating that their latex agglutination-neg-
ative phenotype was maintained at all stages of growth (data
not shown). Furthermore, for all of these isolates, the neg-
ative latex agglutination phenotype was consistent for both
blood agar-grown colonies and pelleted cells recovered from
BHI broth cultures. All of the Staphaurex-negative isolates
TABLE 1. Oligonucleotide primers used in this studyi
Target gene Nucleotide sequence (5	–3	) Referenceor source
Primers for gene detection by
conventional PCR
spa CAG CAG TAG TGC CGT TTG CTT This study
GAC GAT CCT TCA GTG AGC AAA G This study
clfA CGC CGG TAA CTG GTG AAG CT This study
TGC TCT CAT TCT AGG CGC ACT T This study
clfB ATG ATC TTG CTT GCG TT This study
CCG ATT CAA GAG TTA CAC C This study
fnbA GCG GAG ATC AAA GAC AAG TAa 5
CAC CAT CTA TAG CTG TGT GGa 5
fnbB GGA GAA GGA ATT AAG GCGb,c 5
GCC GTC GCC TTG AGC GTb 5
TSA CAG ARS TTA ACG ACT Gc This study
Primers for entire gene amplification by
conventional PCR
spa ATC AAC GTA TAT AAG TTA AAA TTG GTT TGG A This study
ATA TTT ATT TTA TAA GTT GTA AAA CTT ACC TTT AAA TTT AAT T This study
clfA CAT TAA CAG AGA TTA AAT ATA TCT TTA AAG GGT This study
GGA AAA TCC AAG TAA AAA AGC CAC CT This study
fnbA TTT AAA AAC CGA ACA ATA TAG ACT TGC This study
GAA ATT TGA TTT AAT HTA AAA AAA CAG GYT T This study
Primers for gene expression by qRT-PCRd
spa TTT GTC AGC AGT AGT GCC This study
ACG ATC CTT CAG TGA GC This study
clfA AGA AAC GCC GGT AAC T This study
CTC TCA TTC TAG GCG CAC This study
clfB GCG CAT TGG AAA TCG T This study
AGA GCC AGC TTC AAC A This study
gyrB GTC GAA GGG GAC TCT G This study
GCT CCA TCC ACA TCG G This study
16S rRNA TGT CGT GAG ATG TTG GG This study
CGA TTC CAG CTT CAT GT This study
Primers for detection of sequence
polymorphism by real-time PCR
spae GAG CAT CGT TTA GCT TTT TAG CTT Ah This study
TTC ATT CAA AGT CTT AAA GAC GA This study
clfAf AGA AAC GCC GGT AAC T This study
ACA TAG TCT GTA AAA GTA TAA ATA ACA TTA CCA AAh This study
fnbAg GTG AAT GGT TCG ATT GAG AC This study
CTT TAT ATT TGT TCT TAT CTG ATG CGT CTA Ah This study
a Modified from reference 5 in order to increase the melting temperature.
b Used for Staphaurex-negative isolates and for Staphaurex-positive isolates of spa types t267 and t524.
c Used for Staphaurex-positive isolates apart from those of spa types t267 and t524.
d Primers for qRT-PCR were designed using LightCycler probe design software (Roche Diagnostics 
Schweiz AG, Rotkreuz, Switzerland).
e Specific for premature stop codon in spa for Staphaurex-negative isolates.
f Specific for sequence polymorphism in EF-hand motif of clfA for Staphaurex-negative isolates.
g Specific for sequence polymorphism in fnbA for Staphaurex-negative isolates.
h Bold letters mark sequence polymorphisms at the following positions: for spa, 979; for clfA, 931 and 932; and for fnbA, 1246, 1247, and 1252 to 1254.
i All primers were produced by Microsynth AG, Balgach, Switzerland.
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exhibited alpha-beta hemolysis as well as egg yolk-negative
phenotypes on Baird-Parker agar.
Genetic analysis. All bovine S. aureus isolates, including
those that were negative for latex agglutination, were found to
be positive for the spa, clfA, clfB, and fnbA genes when tested
by PCR. In addition, spa gene amplification gave rise to eight
PCR product band sizes, indicating the polymorphic nature of
the variable proline-rich repeat region within spa genes across
the S. aureus isolate collection examined (data not shown).
Notably, all of the Staphaurex-negative isolates gave the same
amplicon size, indicating that they harbored spa genes with
similar variable repeat region lengths. This observation was
subsequently confirmed by spa typing, which demonstrated
that all Staphaurex-negative isolates were of the t529 spa type
(Table 2). All of the Staphaurex-negative isolates were nega-
tive for fnbB, whereas all but five Staphaurex-positive isolates
were found to be fnbB positive by PCR (data not shown). Next,
the isolates were further typed based on agr genetic polymor-
phisms, since agr constitutes one of the global virulence gene
expression regulators that control spa and fnbA and -B expres-
sion, which might thus also influence latex agglutination phe-
notypes. All of the Staphaurex-negative isolates were of agr
FIG. 1. Box plots showing the spa, clfB, and clfA relative gene expression levels in Staphaurex-negative (n  17) and -positive (n  11) bovine
mastitis S. aureus isolates. Staphaurex-negative isolates showed significantly (*, P 0.05) lower expression of spa but significantly higher expression
of clfA than did Staphaurex-positive isolates. No significant differences were detected in clfB relative gene expression levels between the two groups
of S. aureus isolates.
TABLE 2. Phenotypic and genotypic characteristics of 79 bovine mastitis S. aureus isolates
No. of
isolates
in group
Staphaurex
test result spa type/CC
a
No. of
repeats in
proline-rich
repeat
region of spa
agr
type
MLST /CC (no. of
typed isolates)b
Hemolysis type(s)
(no. of isolates)
Egg yolk
reaction(s)
(no. of
isolates)
Presence of change in
gene
spac clfAd fnbAe
11  t2953/CC8 10 I ST8/CC8 (1) Delta (6), alpha (4),
none (1)
 No No No
5  t267/CC80 10 I ST352/CC97 (1) Beta  (3)/ (2) No No No
1  t024/CC8 9 I ND Delta  No No No
1  t5268/CC8 9 I ND Delta  No No No
1  t3802/CC8 9 I ND Delta  No No No
1  t034/CC398 9 I ND Alpha-beta  No No No
1  t2094/NA 8 I ND Beta  No No No
1  t7008/NA 7 I ND Alpha-beta  No No No
1  t045/CC5 7 II ND Alpha  No No No
2  t7007/NA 6 II ST479/CC5 (1) Alpha-beta  No No No
3  t7013/NA 5 II ST479/CC5 (1) Alpha-beta  (2)/ (1) No No No
1  t1403/CC133 3 I ST133/CC133 (1) Alpha  No No No
7  t524/CC97 2 I ST71/CC97 (2) Beta  No No No
43  t529/CC151 2 II ST504/CC705 (2) Alpha-beta  Yes Yes Yes
a NA, not assignable.
b ND, not determined.
c Premature stop codon in spa, detected by sequencing or real-time PCR.
d Sequence polymorphism in EF-hand motif of clfA, detected by sequencing or real-time PCR.
e Sequence polymorphism at base positions 1246, 1247, and 1252 to 1254 in fnbA, detected by sequencing or real-time PCR.
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type II (Table 2). In contrast, the majority (84%) of Staphau-
rex-positive isolates were of agr type I, apart from the isolates
harboring spa type t045, t7007, or t7013, which were of agr type
II. Nine isolate representatives were selected from this S. au-
reus collection and subjected to further analysis by MLST.
These results are also presented in Table 2.
spa, clfA, clfB, and fnbA gene expression analysis. The levels
of spa, clfA, clfB, and fnbA gene transcripts in stationary-phase
cells of selected Staphaurex-negative (n  17) and -positive
(n 11) isolates were determined by real-time qRT-PCR. Box
plots summarizing the relative spa, clfA, and clfB gene expres-
sion levels across the Staphaurex-negative and -positive groups
are presented in Fig. 1. As shown, we found that spa transcript
levels across the Staphaurex-negative group were significantly
(P  0.05) below those of the Staphaurex-positive group. The
expression of clfA, on the other hand, was significantly (P 
0.05) higher for the Staphaurex-negative group than for the
Staphaurex-positive group. In contrast, there were no signifi-
cant differences (P  0.05) in both clfB and fnbA gene expres-
sion levels (data not shown) between these two groups.
Evaluation of spa, clfA, and fnbA gene sequences. The spa,
clfA, and fnbA gene sequences were determined in a selection
of Staphaurex-negative and -positive isolates (Table 3). The
spa gene sequences from all sequenced Staphaurex-negative
isolates featured a G-to-T base change at position 979, which
leads to a premature stop codon after 326 amino acids in the
translated SpA protein sequence. In contrast, none of the
sequenced Staphaurex-positive isolates had similar changes in
their respective spa sequences.
The ClfA lengths based on the determined full-length clfA
gene sequences ranged from 854 to 934 amino acids in the
different S. aureus isolates. All sequenced Staphaurex-negative
isolates displayed GA-to-TT nucleotide differences at positions
931 and 932 compared to the Newman reference strain se-
quence (30). This change in the clfA sequence resulted in a
D311F amino acid change in the ClfA protein sequence.
The major genetic variations found in the Staphaurex-neg-
ative isolate fnbA sequence compared to the NCTC 8325-4
reference strain (23) included an A416L amino acid change
due to GCA-to-TTA base changes at positions 1246 to 1248, as
TABLE 3. Sequence polymorphisms found in sequenced spa, clfA, and fnbA genes
Relevant gene and spa
type or reference strain
(no. of isolates)
Staphaurex
test result Relevant sequence
i Positiona Reference
spa
t529 (5)  CAAAGAAATTTTAGCATAA 979 This study
All other typesb (11)  CAAAGAAATTTTAGCAGAA 982–984 This study
clfA
Newmanc GAT GGT 934–939d 30
DS D G NVIYTFTD 310–321
t529 (4)  TTT GGT 931–932 This study
DS F G NVIYTFTD 311
t7007 (1)/t7013 (2)  GAT GAT 938 This study
DS D D NVIYTFTD 313
t2953 (1)/t267 (1)  GAT GGT 934–939 This study
DS D G NVIYTFTD 312–313
fnbA
NCTC 8325-4e GCA AAT ACG 1243–1251f 23
A N T 415–417 (I)g
t529 (3)  TTA GAC GCA 1246/1247/1252/1254 This study
L D A 416/418 (VI)g
t524 (1)  GCA AAC ATA 671–672h This study
A N I 224
t2953 (1)  GCA AAT ACG 664–672h This study
A N T 222–224
a Nucleotide or amino acid sequence-based regions of interest in S. aureus reference strains and bovine mastitis isolates. Position numberings in some cases differ
due to gene length differences in the respective S. aureus reference strains and examined isolates.
b The other sequenced spa genes of our Staphaurex-positive isolates of spa types t2953, t267, t7007, t7013, t1403, and t524.
c Available in the GenBank database (http://www.ncbi.nlm.nih.gov/GenBank/index.html) under GenBank accession no. Z18852.1 (October 2010) (28) (bases 302 to 3103).
d Positions based on the clfA part of sequence Z18852.1 only (bases 302 to 3103  positions 1 to 2802).
e Available under GenBank accession no. J04151.1 (October 2010) (33) (bases 118 to 3174).
f Positions based on the fnbA part of sequence J04151.1 only (bases 118 to 3174  positions 1 to 3057).
g Positions 415 to 417 in FnbpA isoform I (27) are positions 416 to 418 in isotype VI.
h N2,N3 (fibrinogen-binding) domain only was sequenced, and positions are based on the N2,N3 domain in NCTC 8325-4 (bases 697 to 1650  positions 1 to 954).
i Bold letters indicate nucleotide base changes in Staphaurex-negative S. aureus isolates, underlining indicates condon or amino acid changes detected in both
Staphaurex-positive and -negative isolates compared to the reference S. aureus strains, and letters in italic indicate nucleotide base changes in Staphaurex-positive
S. aureus isolates.
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well as a T418A amino acid change due to ACG-to-GCA base
changes at positions 1252 to 1254.
All of these genetic variations in spa, clfA, and fnbA were
confirmed to be present in the rest of the Staphaurex-negative
S. aureus isolates (Table 2) by use of a real-time PCR and
primer sets that were specifically designed to detect these se-
quence variations. In contrast, none of these genetic changes
were detected in any of the Staphaurex-positive isolates exam-
ined in this study.
SpA detection by immunoblotting. The expression of SpA
was examined at the protein level in four selected isolates,
representing two Staphaurex-positive and two Staphaurex-neg-
ative isolates. To achieve this, supernatant, cell wall, cytoplas-
mic, and membrane protein fractions as well as total protein
were extracted from two Staphaurex-positive (spa types t2953
and t524) and two Staphaurex-negative isolates. As an exam-
ple, immunoblotting results are shown in Fig. 2, where goat
anti-human IgA-binding activity was assessed in the cell wall
fractions and culture supernatants. As shown for both
Staphaurex-positive isolates, bands corresponding to the ex-
pected size of translated full SpA (55 kDa for spa type t2953
and 48 kDa for spa type t524) were detected. In contrast, there
was no corresponding SpA-associated human IgG-binding ac-
tivity detected in samples derived from the two Staphaurex-
negative isolates.
DISCUSSION
The latex agglutination-based Staphaurex test kit is reported
to have a specificity and sensitivity of 99.5% and 99.8%, re-
spectively, when applied to S. aureus isolates of human origin,
according to the information provided by the kit manufacturer.
However, in the present study, a high frequency (54%) of
Staphaurex-negative results was found among PCR-confirmed
S. aureus isolates of bovine mastitis origin. Since Atkins et al.
(3) did not detect any host species-specific selection for immu-
noglobulin binding in SpA, we hypothesized that there might
be differences in the execution of protein-protein interactions
(SpA with human IgG and/or ClfA, ClfB, FnbA, or FnbB with
human fibrinogen) between the latex agglutination-negative
and -positive S. aureus isolates examined in our study. Possible
reasons for Staphaurex-negative results might include loss or
inadequate expression of one or more Staphaurex-targeted S.
aureus genes (spa, clfA, clfB, fnbA, and fnbB). Moreover, nat-
ural genetic variability among isolates might result in adhesion
proteins that are impaired in interaction with the human IgG
and fibrinogen targets which are coupled to the latex particle
surfaces in the Staphaurex test kit.
All of the latex agglutination-negative S. aureus isolates of
bovine mastitis origin examined in our study possessed the spa,
clfA, clfB, and fnbA genes. However, some key genetic differ-
ences were detected in the spa, clfA, and fnbA gene sequences
of Staphaurex-negative isolates. These differences lead to trun-
cated SpA proteins as well as to ClfA and FnbA proteins that
may have lower fibrinogen-binding affinities.
All Staphaurex-negative S. aureus isolates examined dis-
played a genetic change in spa that leads to a premature stop
codon and a truncated SpA protein. This premature stop
codon is located within the fifth IgG-binding domain of SpA,
which leaves the proline-rich repeat, cell wall, and membrane-
spanning regions of the protein untranslated. As a result, such
SpA proteins might not be anchored to the S. aureus cell
surface because they lack the sortase motif (LPETG) and
therefore would not be able induce latex agglutination reac-
tions in the Staphaurex test. Moreover, based on Western
immunoblotting, the truncated SpA protein, if expressed in
Staphaurex-negative S. aureus isolates, seems to have a signif-
icantly impaired immunoglobulin-binding affinity. Interest-
ingly, the same genetic change leading to SpA truncation is
present within the spa gene of ET3-1 (RF122; GenBank ac-
cession no. AJ938182.1), the only S. aureus strain of bovine
origin to date whose genome has been sequenced completely
(19).
In addition, there were clfA genetic polymorphisms detected
in all of the Staphaurex-negative isolates that induced an
amino acid change at position 311, within the ClfA Ca2-
binding EF-hand motif. Similar mutations have previously
been found to reduce fibrinogen-binding affinity when artifi-
cially introduced into the S. aureus Newman strain ClfA pro-
tein (30). The amino acid at position 311 is a cation-coordi-
nating residue, and only acidic (D) or polar (N/S) amino acids
are predicted to be functionally acceptable residues in this
position. O’Connell et al. (30) showed that while a D310A
mutation had no effect on fibrinogen binding, a D310A and
D312A double mutation induced a 3-fold reduction in the ClfA
fibrinogen-binding capacity of the Newman strain. We there-
fore assumed that the D311F (D312A in strain Newman)
change observed in our Staphaurex-negative isolates might
also lead to reduced ClfA fibrinogen-binding activity because
phenylalanine, like alanine, is a nonpolar amino acid, which is
a functionally nonacceptable residue in this position. Herron-
Olson et al. (19) showed that clfA of ET3-1 contains a prema-
ture stop codon due to an adenine (A) deletion between po-
FIG. 2. Western blot analysis of cell wall fractions and supernatants
of Staphaurex-positive and -negative bovine mastitis S. aureus isolates.
Proteins derived from the cell wall fractions of stationary-phase BHI
cultures and their concentrated supernatants were resolved by SDS-
PAGE. The proteins were analyzed by Western immunoblotting using
an HRP-conjugated goat anti-human IgA. Lane 1, molecular size
marker; lanes 2 and 6, Staphaurex-positive S. aureus isolate 1887; lanes
3 and 7, Staphaurex-positive S. aureus isolate 1917; lanes 4 and 8,
Staphaurex-negative S. aureus isolate 1910; lanes 5 and 9, Staphaurex-
negative S. aureus isolate 2188. The expected SpA protein sizes are
57.2 (520 aa) and 50.1 (456 aa) kDa for Staphaurex-positive isolates
1887 and 1917, respectively. In the Staphaurex-negative isolates 1910
and 2188, the expected truncated SpA protein size would be 35.8 kDa
(326 aa).
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sitions 36 and 42 (with ATG as the start codon), which results
in a translational frameshift, leading to several premature stop
codons in the translated protein. To examine such a possibility
within the clfA genes of the S. aureus isolates in the present
study, some Staphaurex-negative and -positive isolates as well
as the ET3-1 strain were sequenced. The resequencing of clfA
in ET3-1 confirmed the previously described A deletion, but
none of the sequenced clfA genes of our Staphaurex-positive
and -negative isolates displayed any base deletion that would
result in such a translational frameshift.
Moreover, all Staphaurex-negative isolates examined in our
study harbored A416L and T418A amino acid changes in
FnbA. Interestingly, amino acid changes at the same positions,
introduced by mutagenesis into the NCTC 8325-4 reference
strain, were shown to significantly reduce the fibrinogen-bind-
ing capacity of FnbA (23). The same fnbA genetic polymor-
phisms as those in our Staphaurex-negative isolates were also
observed in the sequenced ET3-1 strain (19). Seven FnbA
isotypes have been defined (27). The FnbA sequences deter-
mined for the Staphaurex-negative isolates of our collection
were all of isotype VI. These isolates have one amino acid
more than the protein of NCTC 8325-4 (isotype I), preceding
the amino acid changes mentioned above. Therefore, amino
acid positions 416 to 418 in our Staphaurex-negative isolates
correspond to positions 415 to 417 in NCTC 8325-4. An addi-
tional N417D FnbA amino acid change was found in all of the
sequenced Staphaurex-negative isolates, but its potential im-
pact on fibrinogen binding is presently unknown.
The contribution of S. aureus FnbB to the latex agglutination
reaction has been demonstrated previously. By expressing Fn-
bpB of strain 8325-4 of Staphylococcus carnosus, Grundmeier
et al. (14) showed that FnbB alone was sufficient to cause latex
agglutination. Meanwhile, all Staphaurex-negative isolates, in-
cluding ET3-1, failed to give a PCR product when amplified
with a set of primers targeting the fnbB gene, as previously
described (5). Although it cannot be ruled out completely that
the primer set used might fail to amplify the different FnbpB
isotypes due to possible sequence polymorphisms in primer
binding regions (6), we presume that similar to ET3-1, our
Staphaurex-negative isolates also lack the fnbB gene.
It is interesting that the latex agglutination-negative S. au-
reus isolates in our study share various phenotypic and genetic
similarities with the ET3-1 strain, which is a member of one of
the most abundant S. aureus lineages associated with intra-
mammary infection of cows from diverse localities (22). Spe-
cifically, we found that compared to the Staphaurex-negative
bovine mastitis-derived S. aureus isolates of our study, the
ET3-1 strain is also Staphaurex negative, shows alpha-beta
hemolysis, is of spa type t529 and agr type II, and displays the
same key genetic changes in spa and fnbA. Additionally, ET3-1
belongs to ST151, whereas our Staphaurex-negative isolates
belong to ST504, sharing five of seven loci with ST151. Both
MLST types are grouped into the same 705 clonal complex
(17).
Another remarkable observation was that some of the
clfA and fnbA genetic changes that were originally discov-
ered through artificial mutagenesis in laboratory strains to
reduce the fibrinogen-binding capacities of ClfA and FnbA,
respectively, were also found to occur naturally in latex
agglutination-negative S. aureus isolates, as shown in the
present study.
Meanwhile, it was interesting that all Staphaurex-negative
S. aureus isolates were of agr type II, while the majority
(83%) of Staphaurex-positive isolates were of agr type I. The
dominance of agr types I and II in bovine S. aureus isolates
was also shown previously by Gilot et al. (12). Buzzola et al.
(7) demonstrated that agr type II S. aureus isolates displayed
a significantly decreased level of internalization into MAC-T
(bovine mammary epithelial cell line) cells in vitro. One
plausible hypothesis would be that this might be linked to a
higher degree of suppression of spa and fnbA and -B expres-
sion by agr type II than by agr type I isolates, but this
remains to be investigated. Our gene expression results
showed low spa expression levels in agr type II-harboring
Staphaurex-negative isolates as well as in the few Staphau-
rex-positive isolates also harboring the agr type II sequence.
An inverse relationship between alpha hemolysis and SpA,
both of which are regulated by agr, was found by Takeuchi
et al. (38) for bovine mastitis-derived S. aureus isolates.
Similar observations were made in our current study, as all
of the Staphaurex-negative isolates displayed alpha-beta he-
molysis and little spa gene expression, while 54% of
Staphaurex-positive isolates displayed only delta or beta
hemolysis and relatively higher spa expression levels.
Despite the expression of clfA in stationary-phase cultures,
Staphaurex-negative isolates were found in great numbers, in-
dicating the possible impact of the amino acid change within
the EF-hand motif of ClfA in fibrinogen binding. Meanwhile,
our observation that clfB was lowly expressed in stationary-
phase cultures (Fig. 1) parallels observations by Ní Eidhin et al.
(29), who detected ClfB only on cells grown to early exponen-
tial phase. ClfB might no longer be present on the cell surfaces
of most stationary-phase cells, thereby contributing less to fi-
brinogen binding during latex agglutinaton in Staphaurex test.
The reasons for latex agglutination-negative results pre-
viously mentioned in the literature include experimental
differences, missing S. aureus surface proteins, and the use
of nonhuman IgG (45). Our observations here suggest that,
in the Staphaurex-negative S. aureus isolates examined, the
SpA protein is truncated and not attached to the cell wall.
Furthermore, this protein might not be expressed suffi-
ciently in Staphaurex-negative isolates, based on our qRT-
PCR results. Even if it is expressed at the protein level, the
expressed form of this SpA protein might have poor immu-
noglobulin-binding activity, since it could not be detected by
immunoblotting. Either way, the SpA protein in Staphaurex-
negative isolates seems not able to participate in latex ag-
glutination reactions. On the other hand, there were no
significant differences in clfB and fnbA (data not shown)
transcript levels between Staphaurex-positive and -negative
isolates, while clfA transcripts were higher in Staphaurex-
negative isolates. It still remains to be determined if these
differences are reflected at the protein expression and func-
tional levels. Protein sequence analysis suggests, however,
that the ClfA and FnbA proteins in S. aureus isolates might
be impeded from giving observable positive latex agglutina-
tion phenotypes due to their impaired binding to the fibrin-
ogen molecules that are coupled to the latex particles in the
Staphaurex kit.
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The Staphaurex-positive isolates described in this study,
on the other hand, constituted a more diverse group. As
shown in Table 2, this category included isolates displaying
alpha, beta, alpha-beta, or delta hemolysis and one nonhe-
molytic isolate, as well as isolates that were positive or
negative for the egg yolk reaction. Moreover, there were 13
different spa types present, with at least 6 different MLST
types and 2 agr types: 83% (30/36 isolates) of the isolates
were of agr type I, and 17% (6/36 isolates) were of agr type
II. Sequenced FnbA proteins (N2,N3 region) were of iso-
types I (spa type t2953) and IV (spa type t524) (27). None of
the Staphaurex-positive S. aureus isolates harbored any of
the genetic changes observed in the Staphaurex-negative S.
aureus isolates, apart from a few Staphaurex-positive iso-
lates that failed to give a PCR band corresponding to fnbB
amplification. As already mentioned, the failure to give fnbB
amplicons might also be due to the fact that the primer set
applied might not capture all FnbB isotypes.
As shown in the present study, the Staphaurex-negative
phenotype observed in 54% of isolates might be linked to
genetic changes affecting the interaction of SpA, ClfA, ClfB,
and FnbpA with host IgG and fibrinogen, which might also
have virulence implications for the respective S. aureus iso-
lates. This study included five S. aureus isolates that were
associated with mastitis herd problems. Interestingly, four of
these isolates were Staphaurex positive, and only one was a
Staphaurex-negative isolate. This Staphaurex-negative
S. aureus isolate was detected with a Staphaurex-positive S.
aureus isolate in the same herd. Thus, its independent role
in this mastitis herd problem cannot be confirmed. Since
SpA, ClfA, and FnbA and -B are important S. aureus viru-
lence factors, their impaired functionality in Staphaurex-
negative isolates may be presumed to lead to reduced viru-
lence. However, such a hypothesis awaits further
experimental confirmation. If it holds true, the Staphaurex
test kit could potentially serve as an important diagnostic
tool for rapid differentiation of more or less virulent S.
aureus isolates in association with bovine mastitis.
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